Diuretic Versus -Blocker as First-Step Antihypertensive Therapy

  • Published 2003


The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) was a randomized, double-blind, active, controlled clinical trial conducted to determine whether newer antihypertensive agents, including doxazosin, an -blocker, differ from chlorthalidone, a diuretic, with respect to coronary heart disease (CHD) and other… (More)


6 Figures and Tables

Cite this paper

@inproceedings{2003DiureticV, title={Diuretic Versus -Blocker as First-Step Antihypertensive Therapy}, author={}, year={2003} }